Remove Networking Remove Pharma Remove Pharmaceutical products Remove Transportation
article thumbnail

Strengthening and transforming the pharmaceutical supply chain

European Pharmaceutical Review

Recommendations were also published earlier this year for all stakeholders in the pharma supply chain. In this Q&A EPR speaks to Naser Al Yammahi the Deputy CEO of Hayat Biotech about pharmaceutical supply chain challenges and how they can be addressed. What types of medicinal products are in short supply and why?

article thumbnail

Pharma’s climate change vulnerability and opportunity

pharmaphorum

As one of the world’s biggest contributors to climate change, pharma is morally obliged to adapt its processes and operations – and doing so will open up new opportunities for growth. Pharma’s reliance on global supply chains and its need for vast quantities of water make it particularly vulnerable to climate change. Responsibility .

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

The Value of Precision Livestock Farming (PLF) in 2022

Celeritas

Other sensors include pedometers , accelerometers , pressure sensors , and temperature sensors which are often integrated into foot tags to detect estrus, ill health, and weight gain and connected to a network to establish an Internet of Things. Utilize by-products such as gelatin, leather, and internal organs most efficiently and profitably.

article thumbnail

The impact of climate change on the pharma supply chain

Pharmaceutical Technology

Pharmaceutical companies need to be prepared to answer the call for increased demand and supply into new markets, ensuring the proper resources and logistics framework are in place. Consumers are taking notice of these metrics, and there is demand for action from pharma.

Pharma 142
article thumbnail

Using big data to stabilise pharma supply chains in an age of disruption

Pharmaceutical Technology

Big data analysis can be enormously powerful in providing insights for business strategy throughout the pharma value chain, including in the acceleration of drug discovery and development, optimization of manufacturing processes, management of supply chains and the creation of innovative sales and marketing strategies.

Pharma 52